End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
819.2 INR | +0.52% | +2.06% | +24.68% |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Chart calendar Glenmark Life Sciences Limited
Upcoming events on Glenmark Life Sciences Limited
Past events on Glenmark Life Sciences Limited
2024-04-25 06:30 am | Q4 2024 Earnings Call |
2024-04-25 05:20 am | Q4 2024 Earnings Release |
2024-03-14 | Non Deal Roadshow - Day 4 |
2024-03-13 | Non Deal Roadshow - Day 3 |
2024-03-12 | Non Deal Roadshow - Day 2 |
2024-03-11 | Non Deal Roadshow - Day 1 |
2024-01-23 10:00 pm | Q3 2024 Earnings Call |
2024-01-23 06:50 am | Q3 2024 Earnings Release |
2023-10-20 06:30 am | Q2 2024 Earnings Call |
2023-10-20 03:41 am | Q2 2024 Earnings Release |
2023-09-26 05:30 am | Annual General Meeting |
2023-07-21 06:30 am | Q1 2024 Earnings Call |
2023-07-21 03:25 am | Q1 2024 Earnings Release |
2023-04-27 11:00 pm | Q4 2023 Earnings Call |
2023-04-27 08:10 am | Q4 2023 Earnings Release |
2023-01-27 06:00 am | Q3 2023 Earnings Call |
2023-01-27 02:25 am | Q3 2023 Earnings Release |
2022-10-21 06:30 am | Interim 2023 Earnings Call |
Past dividends on Glenmark Life Sciences Limited
2023-10-16 | Interim Payment 22.5 INR |
2023-03-23 | Interim Payment 21 INR |
2022-09-14 | Final Payment 10.5 INR |
2021-11-21 | Interim Payment 10.5 INR |
Annual results
Fiscal Period | March | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 18 852 | 21 379 21 326 0.25% | 21 612 20 860 3.61% | 22 832 23 913 -4.52% |
EBITDA Million INR | Released Forecast Spread | 0,00 | 6 308 6 205 1.66% | 6 423 5 875 9.33% | 6 742 7 353 -8.31% |
EBIT Million INR | Released Forecast Spread | 0,00 | 5 929 5 790 2.4% | 6 002 5 514 8.85% | 6 208 6 999 -11.3% |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | 5 649 5 611 0.68% | 6 286 5 749 9.35% | 6 313 7 057 -10.54% |
Net income Million INR | Released Forecast Spread | 0,00 | 4 187 4 132 1.33% | 4 670 4 264 9.51% | 4 709 5 213 -9.66% |
EPS INR | Released Forecast Spread | 0,00 | 35,6 33,7 5.71% | 38,1 34,8 9.61% | 38,4 42,5 -9.63% |
Announcement Date | 20/07/21 | 20/04/22 | 27/04/23 | 25/04/24 |
Quarterly results
Fiscal Period | March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 5 639 5 568 1.26% | 5 260 5 363 -1.91% | 5 192 5 002 3.8% | 4 994 5 386 -7.29% | 5 093 5 275 -3.45% | 5 407 5 268 2.64% | 6 213 5 486 13.26% | 5 785 5 842 -0.98% | 5 980 | 6 025 | 6 071 |
EBITDA Million INR | Released Forecast Spread | 1 496 1 590 -5.91% | 1 468 1 389 5.66% | 1 436 1 446 -0.66% | 1 455 1 467 -0.85% | 2 064 1 536 34.39% | 1 932 1 705 13.29% | 2 012 | 1 693 | 1 702 | ||
EBIT Million INR | Released Forecast Spread | 1 598 1 542 3.58% | 1 399 1 452 -3.65% | 1 378 1 330 3.54% | 1 464 1 496 -2.18% | 1 437 1 588 -9.49% | 1 413 1 528 -7.55% | 1 949 1 503 29.66% | 1 824 1 643 11% | 1 947 | 1 708 | |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 820 1 580 15.19% | 1 729 | |||||||||
Net income Million INR | Released Forecast Spread | 1 037 1 121 -7.48% | 1 087 996 9.17% | 1 069 1 039 2.87% | 1 050 1 087 -3.41% | 1 464 1 087 34.64% | 1 355 1 201 12.83% | 1 419 | 1 182 | 1 176 | ||
EPS INR | Released Forecast Spread | 11,1 9,60 15.1% | 10,4 | |||||||||
Announcement Date | 10/11/21 | 08/02/22 | 20/04/22 | 04/08/22 | 21/10/22 | 27/01/23 | 27/04/23 | 21/07/23 | - | - | - |
Past sector events for Glenmark Life Sciences Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLS Stock
- Calendar Glenmark Life Sciences Limited